Analysis of the subsequent treatment of osteoporosis by transitioning from bisphosphonates to denosumab, using quantitative computed tomography: A prospective cohort study

PURPOSE: Denosumab reduces bone resorption and improves bone mineral density (BMD). Studies have analyzed subsequent treatment transitioning from bisphosphonates to denosumab based on dual-energy X-ray absorptiometry scanning (DXA). Quantitative computed tomography (QCT) can help assess cortical and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Bone Rep
Egile Nagusiak: Tsuchiya, Koki, Ishikawa, Koji, Kudo, Yoshifumi, Tani, Soji, Nagai, Takashi, Toyone, Tomoaki, Inagaki, Katsunori
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8170107/
https://ncbi.nlm.nih.gov/pubmed/34113694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2021.101090
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak